Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T18:47:52.012Z.
Calculation as of: 2026-10-06T18:47:52.012Z.
Quote observation: 2026-10-06T18:45:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 033b533528001a3499036996a5838431eca9b2abd512acbebbb4929ff412c5bb
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Sana Biotechnology, Inc.
Market Cap
$781.97M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$778.24M
Operating Cash Flow Yield
1.45%
TTM Avg
5.82%
3Y Avg
10.97%
5Y Avg
8.65%
Market Cap
$786.39M
Operating Cash Flow Yield
74.17%
TTM Avg
47.32%
3Y Avg
42.03%
5Y Avg
31.48%
Market Cap
$782.66M
Operating Cash Flow Yield
N/A
TTM Avg
1.73%
3Y Avg
1.73%
5Y Avg
1.73%
Market Cap
$772.90M
Operating Cash Flow Yield
N/A
TTM Avg
46.70%
3Y Avg
46.70%
5Y Avg
28.34%
Market Cap
$800.49M
Operating Cash Flow Yield
N/A
TTM Avg
0.41%
3Y Avg
2.06%
5Y Avg
3.27%
Market Cap
$763.35M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$803.87M
Operating Cash Flow Yield
11.02%
TTM Avg
10.22%
3Y Avg
10.24%
5Y Avg
8.00%
Market Cap
$759.25M
Operating Cash Flow Yield
7.33%
TTM Avg
8.35%
3Y Avg
7.91%
5Y Avg
6.12%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | $781.97M | N/A | N/A | N/A | N/A |
| Varex Imaging Corporation (VREX)vs › | $778.24M | 1.45% | 5.82% | 10.97% | 8.65% |
| AdaptHealth Corp. (AHCO)vs › | $786.39M | 74.17% | 47.32% | 42.03% | 31.48% |
| Geron Corporation (GERN)vs › | $782.66M | N/A | 1.73% | 1.73% | 1.73% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $772.90M | N/A | 46.70% | 46.70% | 28.34% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $800.49M | N/A | 0.41% | 2.06% | 3.27% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $763.35M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $803.87M | 11.02% | 10.22% | 10.24% | 8.00% |
| Mesa Laboratories, Inc. (MLAB)vs › | $759.25M | 7.33% | 8.35% | 7.91% | 6.12% |
| Apnimed, Inc. (APMD)vs › | $750.67M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
